Skip to content

Net margin at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
21.8%-2.6pp
Amgen logo
AmgenAMGN
21%+3.6pp
Exelixis logo
ExelixisEXEL
35.1%+7.1pp
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
-111.9%-51.5pp
AbbVie logo
AbbVieABBV
5.8%-1.5pp
Nuvation Bio logo
Nuvation BioNUVB
-102.1%-50.6pp

Other financials

Income statement

See full
Revenue$18.3M+29.5%
Gross profit$18.0M
Operating income-$78.8M-21.8%
Net income-$73.3M-27.7%
EPS (diluted)-$0.83-25.8%

Balance sheet

See full
Cash & equivalents$39.1M-23.8%
Total debt$24.3M+25.4%
Total equity$107.9M-70.4%
Total assets$652.6M-12.3%

Cash flow

See full
Operating cash flow-$85.9M-19.4%
CapEx$128.0K-56.2%
Free cash flow-$86.0M-19.1%

Valuation

See full
Market cap$942.78M+86.2%
Enterprise value$927.97M+95.5%
P/S13.2×+3.9×

Profitability

See full
Operating margin-443.5%+103pp
FCF margin130.6%+74.1pp

Returns & leverage

See full
Return on equity-124.7%-252pp
Debt / equity0.2×+0.2×
Current ratio6.1×-1.9×

Where this comes from

Calculated from Kura Oncology’s reported figures.

Based on trailing twelve months.

The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kura Oncology's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kura Oncology's net margin?
Kura Oncology (KURA) reported net margin of -411.2% in Q1 2026.
How has Kura Oncology's net margin changed year-over-year?
Kura Oncology's net margin decreased by 23.3% year-over-year, from -333.6% to -411.2%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.